CXCR4 and small cell lung carcinoma: Among the CK‐positive SCLC patients, 57% (40 out of 70) had the (CK+CXCR4+JUNB+) phenotype and similarly 57% (40 out of 70) had the (CK+CXCR4−JUNB+) phenotype.